Antiplatelet pretreatment and outcomes in intravenous thrombolysis for stroke: a systematic review and meta-analysis.

about

Antiplatelet pretreatment and outcomes in intravenous thrombolysis for stroke: a systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q38760549

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Antiplatelet pretreatment and ...... atic review and meta-analysis.

@en

type

Item

label

Antiplatelet pretreatment and ...... atic review and meta-analysis.

@en

prefLabel

Antiplatelet pretreatment and ...... atic review and meta-analysis.

@en

P1476

Antiplatelet pretreatment and ...... matic review and meta-analysis

@en

P2093

Andrei V Alexandrov

http://www.w3.org/2001/XMLSchema#string

Anne W Alexandrov

http://www.w3.org/2001/XMLSchema#string

Aristeidis H Katsanos

http://www.w3.org/2001/XMLSchema#string

Efthymios Dardiotis

http://www.w3.org/2001/XMLSchema#string

Georgios Tsivgoulis

http://www.w3.org/2001/XMLSchema#string

Martin Köhrmann

http://www.w3.org/2001/XMLSchema#string

Panayiotis D Mitsias

http://www.w3.org/2001/XMLSchema#string

Peter D Schellinger

http://www.w3.org/2001/XMLSchema#string

Sotirios Giannopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

Bias in meta-analysis detected by a simple, graphical test

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Tissue plasminogen activator for acute ischemic stroke

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

A user's guide to the NINDS rt-PA stroke trial database

P2888

s00415-017-8520-1

P304

1227-1235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1007/S00415-017-8520-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

264

http://www.w3.org/2001/XMLSchema#string

P50

Ramin Zand

Vijay K Sharma

P577

2017-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085593360

http://www.w3.org/2001/XMLSchema#string

P698

28550481

http://www.w3.org/2001/XMLSchema#string

P921

thrombolysis